POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 131 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2023. The put-call ratio across all filers is 128.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,409,433 | -28.6% | 2,909,960 | -3.0% | 3.54% | -33.6% |
| Q2 2023 | $27,180,000 | +10.5% | 3,000,000 | -11.3% | 5.32% | +10.2% |
| Q1 2023 | $24,594,621 | +32.7% | 3,383,029 | +33.1% | 4.83% | +33.0% |
| Q4 2022 | $18,529,569 | -32.7% | 2,541,779 | -28.6% | 3.63% | -45.2% |
| Q3 2022 | $27,526,000 | +67.0% | 3,560,984 | +47.1% | 6.63% | +67.7% |
| Q2 2022 | $16,484,000 | +0.4% | 2,420,501 | +17.5% | 3.95% | -0.4% |
| Q1 2022 | $16,418,000 | +1438.7% | 2,060,000 | +981.3% | 3.97% | +1574.3% |
| Q4 2021 | $1,067,000 | – | 190,520 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,420,501 | $16,484,000 | 3.95% |
| Fairmount Funds Management LLC | 1,833,950 | $12,489,000 | 2.86% |
| JOHNSON & JOHNSON | 1,000,000 | $6,810,000 | 1.74% |
| RA Capital Management | 9,003,018 | $61,311,000 | 1.64% |
| Sio Capital Management, LLC | 504,545 | $3,436,000 | 1.29% |
| BVF INC/IL | 3,367,826 | $22,935,000 | 1.11% |
| Boxer Capital, LLC | 2,500,000 | $17,025,000 | 1.08% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $20,528,000 | 0.78% |
| ORACLE INVESTMENT MANAGEMENT INC | 129,810 | $884,000 | 0.27% |
| Perceptive Advisors | 1,073,995 | $7,314,000 | 0.23% |